IDH1 and central nervous system cancer: The IDHR132H mutation, a common IDH1 mutation in glioma, alters the amino acid arginine for histidine at position 132, found in about 5% of primary GBMs despite its prevalence in low-grade gliomas and secondary GBMs [83].